Furthermore, we show that high AGO2 gene expression levels in ERα+ tumors correlate with a poor prognosis, in contrast to a lack of correlation between AGO2 expression levels and clinical outcome for ERα− tumor types. Here, ESR1 is linked to neoplasm.